Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer
Giulia Martini, Valentina Belli, Stefania Napolitano, et al.
ESMO Open (2023) Vol. 8, Iss. 3, pp. 101198-101198
Open Access | Times Cited: 22

Showing 22 citing articles:

Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response
Lidwien P. Smabers, Emerens Wensink, Carla S. Veríssimo, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 10
Exploring Tumor–Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients
S.Y. Jeong, Minyong Kang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14609-14609
Open Access | Times Cited: 21
Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study
Sofie Joris, Hannelore Denys, Joëlle Collignon, et al.
ESMO Open (2023) Vol. 8, Iss. 6, pp. 102041-102041
Open Access | Times Cited: 18
Organoid: Bridging the gap between basic research and clinical practice
Guihu Weng, Jinxin Tao, Yueze Liu, et al.
Cancer Letters (2023) Vol. 572, pp. 216353-216353
Closed Access | Times Cited: 14
A functional personalised oncology approach against metastatic colorectal cancer in matched patient derived organoids
Dexter Kai Hao Thng, Lissa Hooi, Bei En Siew, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 5
Predicting patient outcomes with gene-expression biomarkers from colorectal cancer organoids and cell lines
A. V. Razumovskaya, M. O. Silkina, А. А. Полозников, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Hsa-miR-526b-5p Regulates the Sensitivity of Colorectal Cancer to 5-Fluorouracil by Targeting TP53 in Organoid Models
Leaf Huang, Cun Liao, Zuming Xiong, et al.
Biochemical Genetics (2025)
Closed Access
Patient-Derived Tumor Organoids: A Platform for Precision Therapy of Colorectal Cancer
Yiran Li, Wei Wu, Jiaxin Yao, et al.
Cell Transplantation (2025) Vol. 34
Open Access
PBRM1 deficiency enhances PD1 immunotherapeutic sensitivity via chromosomal accessibility in colorectal cancer
Rui Li, Jie He, Chaoqun Liu, et al.
Theranostics (2025) Vol. 15, Iss. 8, pp. 3316-3331
Open Access
Colorectal Organoids: Models, Imaging, Omics, Therapy, Immunology, and Ethics
Martina Taglieri, Linda Di Gregorio, Serena Matis, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 457-457
Open Access
Systematic review: predictive value of organoids in colorectal cancer
B. Cristoffer Sakshaug, Evelina Folkesson, Tonje H. Haukaas, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Continuous imaging to evaluate growth and drug responses of patient-derived colorectal tumouroids
B. Cristoffer Sakshaug, Evelina Folkesson, Tonje H. Haukaas, et al.
ESMO Gastrointestinal Oncology (2025) Vol. 7, pp. 100137-100137
Open Access
Emerging roles of 3D-culture systems in tackling tumor drug resistance
Amin Nikdouz, Francesca Orso
Cancer Drug Resistance (2023) Vol. 6, Iss. 4, pp. 788-804
Open Access | Times Cited: 9
In-vitro assays for immuno-oncology drug efficacy assessment and screening for personalized cancer therapy: scopes and challenges
M M Rahman, Greg Wells, Juha Rantala, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 8, pp. 821-838
Open Access | Times Cited: 3
Exploring the potential of human intestinal organoids: Applications, challenges, and future directions
Inês A. Parente, Linda Chiara, Simona Bertoni
Life Sciences (2024) Vol. 352, pp. 122875-122875
Open Access | Times Cited: 3
Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening
H. Fang, Haoying Xu, Jiong Yu, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 794-794
Open Access | Times Cited: 3
Challenges in validation of combination treatment strategies for CRC using patient-derived organoids
Valentin Benboubker, George M. Ramzy, S. Jacobs, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Advancements in Research and Treatment Applications of Patient-Derived Tumor Organoids in Colorectal Cancer
Denise van der Graaff, Sofie Seghers, Pieterjan Vanclooster, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2671-2671
Open Access
A Method to Study Migration and Invasion of Mouse Intestinal Organoids
Valérie M. Wouters, Ciro Longobardi, Jan Paul Medema
Organoids (2024) Vol. 3, Iss. 3, pp. 194-202
Open Access
The Use of Patient-Derived Organoids in the Study of Molecular Metabolic Adaptation in Breast Cancer
Natalija Glibetić, Scott Bowman, Tia Skaggs, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10503-10503
Open Access
Patient-derived Organoids as a Tool for Advancing Precision Immuno-oncology
Xin Yi Than, Tiffany T. Ong, Edward Kai‐Hua Chow
(2024) Vol. 01
Closed Access
[Research progress on vascularization of organoids].
Junyi Shen, Zhi Ouyang, Jian Zhong, et al.
PubMed (2023) Vol. 40, Iss. 4, pp. 625-631
Closed Access | Times Cited: 1
Page 1

Scroll to top